WOMEN 'S HEALTH AND MENOPAUSE : - National Heart, Lung ...

REFERENCES
1 NHLBI Morbidity and Mortality Chartbook, 2000.
Morbidity & Mortality: 2000 Chart Book on
Cardiovascular, Lung, and Blood Diseases.
National Institutes of Health, National Heart, Lung,
and Blood Institute. Available at:
http://www.nhlbi.nih.gov/resources/docs/chtbook.htm.
Accessed 14 June 2001.
2 Colditz GA, Willett WC, Stampfer MJ, Rosner B,
Speizer FE, Hennekens CH. Menopause and the
risk of coronary heart disease in women. N Engl J
Med 1987;316(18):1105–10.
3 Anderson KM, Odell PM, Wilson PW, Kannel WB.
Cardiovascular disease risk profiles. Am Heart J
1991;121(1 Pt 2):293–8.
4 Ettinger WH, Wahl PW, Kuller LH, et al. Lipoprotein
lipids in older people. Results from the
Cardiovascular Health Study. The CHS
Collaborative Research Group. Circulation
1992;86(3):858–69.
5 Stampfer MJ, Malinow MR, Willett WC, et al. A
prospective study of plasma homocyst(e)ine and
risk of myocardial infarction in US physicians.
JAMA 1992;268(7):877–81.
6 Greenlund KJ, Srinivasan SR, Xu JH, et al. Plasma
homocysteine distribution and its association with
parental history of coronary heart disease in black
and white children: the Bogalusa Heart Study.
Circulation 1999;99(16):2144–9.
7 Ridker PM, Manson JE, Buring JE, Shih J, Matias M,
Hennekens CH. Homocysteine and risk of cardiovascular
disease among postmenopausal women.
JAMA 1999;281(119):1817–21.
8 Manolio TA, Pearson TA, Wenger NK, Barrett-Connor
E, Payne GH, Harlan WR. Cholesterol and heart
disease in older persons and women. Review of
an NHLBI workshop. Ann Epidemiol
1992;2(1–2):161–76.
168
9 LaRosa JC, He J, Vupputuri S. Effect of statins on risk
of coronary disease: a meta-analysis of randomized
controlled trials. JAMA 1999;282(24):2340–6.
10 Bass KM, Newschaffer CJ, Klag MJ, Bush TL.
Plasma lipoprotein levels as predictors of cardiovascular
death in women. Arch Intern Med
1993;153(19):2209–16.
11 Bengtsson C, Björkelund C, Lapidus L, Lissner L.
Associations of serum lipid concentrations and
obesity with mortality in women: 20 year follow up
of participants in prospective population study in
Gothenburg, Sweden. BMJ
1993;307(6916):1385–8.
12 LaRosa JC. Triglycerides and coronary risk in women
and the elderly (review). Arch Intern Med
1997;157(9):961–8.
13 Sandholzer C, Saha N, Kark JD, et al. Apo(a) isoforms
predict risk for coronary heart disease. A
study in six populations. Arterioscler Thromb
1992;12(10):1214–26.
14 Shlipak MG, Simon JA, Vittinghoff E, et al. Estrogen
and progestin, lipoprotein (a), and the risk of recurrent
coronary heart disease events after menopause.
JAMA 2000;283(14):1845–52.
15 Orth-Gomer K, Mittleman MA, Schenck-Gustafsson
K, et al. Lipoprotein (a) as a determinant of coronary
heart disease in young women. Circulation
1997;95(2):329–34.
16 Manson JE, Tosteson H, Ridker PM, et al. The primary
prevention of myocardial infarction. N Engl J
Med 1992;326(21):1406–16.
17 Wilhelmsen L. Coronary heart disease: epidemiology
of smoking and intervention studies of smoking.
Am Heart J 1988;115(1 Pt 2):242–9.